High-Risk Prostate Cancer: The Rationale for Brachytherapy
In the realm of general oncology, patients who present with aggressive, poorly differentiated malignancies are usually at high risk for disseminated disease, and systemic therapy often supersedes local therapy in importance. It is not surprising, then, that a similar systemic approach to therapy is often considered for patients who present with high-risk prostate cancer. This recommendation is often supported by much of the surgical literature that cites discouraging outcomes in these patients when treated by radical prostatectomy alone.
e16106Background: The prognostic significance and optimal management of pancreatic metastases in renal cell carcinoma (RCC) remains unknown. This study aims to identify factors associated with impr...